# The ED95 of Single Intravenous Bolus Remimazolam Besylate in Pediatric Patients During General Anesthesia Induction

> **NCT06061159** · PHASE4 · COMPLETED · sponsor: **Second Affiliated Hospital of Wenzhou Medical University** · enrollment: 120 (actual)

## Conditions studied

- Pediatric
- ED95
- Sedation
- General Anesthesia

## Interventions

- **DRUG:** Remimazolam besylate
- **DRUG:** Remimazolam besylate

## Key facts

- **NCT ID:** NCT06061159
- **Lead sponsor:** Second Affiliated Hospital of Wenzhou Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-06
- **Primary completion:** 2024-02-27
- **Final completion:** 2024-02-27
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2025-02-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06061159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06061159, "The ED95 of Single Intravenous Bolus Remimazolam Besylate in Pediatric Patients During General Anesthesia Induction". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06061159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*